Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Population-based colorectal cancer screening: Interval cancers and relationship ...
Journal Information
Vol. 152. Issue 8.
Pages 303-306 (April 2019)
Share
Share
Download PDF
More article options
ePub
Visits
0
Vol. 152. Issue 8.
Pages 303-306 (April 2019)
Brief report
Population-based colorectal cancer screening: Interval cancers and relationship with the quantitative faecal immunological for hemoglobin
Cribado poblacional de cáncer colorrectal: cánceres de intervalo y relación con el resultado cuantitativo del test inmunológico de sangre oculta en heces
Visits
...
Andrea Buróna,b,c,
Corresponding author
aburon@parcdesalutmar.cat

Corresponding author.
, Francesc Maciàa,b,c, Montserrat Andreub,d, Maria Pellisée,f,g, Xavier Castellsa,b,c, Jaume Graug,h
a Servicio de Epidemiología y Evaluación, Hospital del Mar, Barcelona, Spain
b IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
c REDISSEC (Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas), Madrid, Spain
d Servicio de Gastroenterología, Hospital del Mar, Barcelona, Spain
e Servicio de Gastroenterología, Hospital Clínic, Barcelona, IDIBAPS, Barcelona, Spain
f Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain
g Universidad de Barcelona, Barcelona, Spain
h Servicio de Preventiva y Epidemiología, ICMID, Hospital Clínic, Barcelona, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (2)
Table 1. Total participants, and total screening and interval cancers in persons with a previous negative FIT result from the BCN programme in round 1 and round 2.
Table 2. Comparison between the characteristics of the interval cancer and the screening cancer cases (diagnosed in the programme) in rounds 1 and 2.
Show moreShow less
Abstract
Introduction and objective

The sensitivity of colorectal cancer screening programmes determines their effectiveness and is directly related to the interval cancer (IC). This study describes the frequency and characteristics of the IC of the Programme of Barcelona, Spain, and analyses its relationship with the quantitative value of the screening test (FIT).

Material and methods

ICs after negative FIT of the first two rounds of the Programme (2010–2013) were included, observation period until July 2017. The information source of the ICs was their notification by professionals and patients, hospital databases and CMBD (Spanish Minimum Basic Data Set).

Results

The sensitivity of the Programme is 82%. ICs are diagnosed more in proximal and rectal colon and in advanced stages than screening cancers, and have higher FIT values than overall people with negative FIT.

Conclusions

The sensitivity is acceptable and comparable to that of other programmes. The quantitative value of FIT in people with negative test should be included in the personalisation strategies of screening to reduce the risk of IC.

Keywords:
Colorectal neoplasms
Screening
Interval cancer
Resumen
Introducción y objetivo

La sensibilidad de los programas de cribado de cáncer colorrectal determina su efectividad y está directamente relacionada con el cáncer de intervalo (CI). Este estudio describe la frecuencia y las características de los CI del Programa de la ciudad de Barcelona y analiza su relación con el valor cuantitativo del test de cribado previo (FIT).

Material y métodos

Se incluyen los CI tras FIT negativo de las primeras dos rondas del Programa (2010-2013); periodo de observación hasta julio de 2017. La fuente de información de los CI es su notificación por profesionales y pacientes y el cruce de bases de datos hospitalarias y CMBD.

Resultados

La sensibilidad del Programa es del 82%. Los CI se diagnostican más en colon proximal y recto y en estadios avanzados que los cánceres de cribado, y presentan valores FIT más elevados que el conjunto de personas con FIT negativo.

Conclusiones

La sensibilidad obtenida es aceptable y comparable a la de otros programas. El valor cuantitativo del FIT en personas con test negativo debería incluirse en las estrategias de personalización del cribado para reducir el riesgo de CI.

Palabras clave:
Cáncer colorrectal
Cribado
Cáncer de intervalo

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos